Pharvaris presents data at the Bradykinin Symposium 2024 Pharvaris announced a summary of data being presented at the ongoing 7th Bradykinin...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Rubriques :
Maroc - HAEI.ORG - A La Une - 28/Aug 17:26
Deucrictibant clinical, real-World, nonclinical, and discovery data to be presented at the Bradykinin Symposium
Deucrictibant clinical, real-World, nonclinical, and discovery data to be presented at the Bradykinin Symposium Pharvaris announced the acceptance of two abstracts for oral presentation and ten abstracts for poster presentation at the upcoming 7th Bradykinin Symposium, to be held from 5-6 September 2024, in Berlin, Germany. Presentation details are as follows: Title: Bradykinin Challenge [...]
Articles similaires
Pharvaris presents deucrictibant long-term extension data for both the prophylactic and on-demand treatment of HAE at the Bradykinin Symposium 2024
haei.org - 05/Sep 18:45
Pharvaris presents deucrictibant long-term extension data for both the prophylactic and on-demand treatment of HAE at the Bradykinin Symposium 2024...
Pharvaris provides business update and expands development program for deucrictibant
haei.org - 05/Sep 18:44
Pharvaris provides business update and expands development program for deucrictibant Pharvaris today announced: The planned initiation of CHAPTER-3,...
BioCryst presents new Orladeyo (berotralstat) data at 7th Bradykinin Symposium
haei.org - 06/Sep 18:48
BioCryst presents new Orladeyo (berotralstat) data at 7th Bradykinin Symposium BioCryst Pharmaceuticals today announced the presentation of six...
KalVista Presents Sebetralstat Data at Bradykinin Symposium 2024
haei.org - 06/Sep 18:54
KalVista Pharmaceuticals Presents Sebetralstat Data at Bradykinin Symposium 2024 KalVista Pharmaceuticals announced that it presented additional...
Cytovation to present safety and efficacy data from CICILIA phase I/IIa clinical trial evaluating CY─101 in solid tumors
pharmabiz.com - 01:13
Cytovation ASA, a clinical stage oncology company focused on the development of its first─in─class bifunctional immunotherapy CY─101 (CyPep─1)...
Les derniers communiqués
-
Aucun élément